Familial hypercholesterolemia linked to higher pre-eclampsia rates

Familial Hypercholesterolemia Study Links Inherited Cholesterol to Pre-Eclampsia Rates

Women living with familial hypercholesterolemia face an 11 percent prevalence rate of pre-eclampsia compared to 7 percent in matched control groups, according to a study published in the European Journal of Preventive Cardiology and detailed by News-Medical. Familial hypercholesterolemia is an inherited condition that causes lifelong high cholesterol, characterized by elevated levels of low-density lipoprotein, or bad cholesterol. The condition affects approximately 1 in 200 to 300 individuals, though most remain undiagnosed.

Key Clinical Takeaways:
• Researchers in the Netherlands and Norway compared 484 women with familial hypercholesterolemia against 968 matched controls aged 40 and older.
• The observational study identified an 11 percent pre-eclampsia rate among women with the inherited condition versus 7 percent in the control group.
• Study authors emphasize that the findings do not establish a direct causal link, nor do they mean every woman with the condition will develop pre-eclampsia.

Netherlands and Norway Observational Research Design

Researchers recruited participants in the Netherlands and Norway between 2023 and 2025 to examine the intersection of reproductive health and inherited lipid disorders. Women with familial hypercholesterolemia were matched 1:2 to control participants based on age, smoking status, body mass index, and ethnicity. Information regarding reproductive factors and pregnancy outcomes was gathered via online surveys. The study population predominantly included women of European ancestry, which researchers noted limits generalizability to other demographic groups.

While pre-eclampsia appeared more frequently in the familial hypercholesterolemia cohort, researchers found comparable numbers of total pregnancies across both groups. Statistical analysis revealed no significant differences in other reproductive health outcomes between women with the inherited condition and the control participants.

Medical Experts Evaluate Pre-Eclampsia Risks and Study Limitations

Pre-eclampsia involves high blood pressure during pregnancy accompanied by organ damage, potentially leading to complications such as slowed fetal growth and premature birth. Professor Jeanine Roeters van Lennep from Erasmus MC University Medical Center Rotterdam stated that the difference in pre-eclampsia prevalence was modest, noting that researchers hope patients feel reassured by the lack of significant variations in other reproductive outcomes.

Study author Janneke Mulder from Erasmus MC University Medical Center Rotterdam emphasized that because the work was an observational study, researchers cannot conclude that familial hypercholesterolemia or elevated LDL cholesterol directly causes pre-eclampsia. Mulder suggested that reproductive health counseling should be considered as part of cardiovascular care for women with familial hypercholesterolemia. Women managing the inherited condition who are planning a pregnancy should consult their healthcare team to review cardiovascular risk factors, blood pressure, and the management of lipid-lowering treatments.

Future Longitudinal Research Directions

Researchers noted that most women with familial hypercholesterolemia in the study were taking lipid-lowering therapies, though many likely started those treatments in their thirties or forties when medications became widely available. Investigators highlighted the need for further research to determine whether earlier or more intensive lipid-lowering interventions might reduce pre-eclampsia risk.

Julie van Oortmerssen, a study author from Erasmus MC University Medical Center Rotterdam, advocated for broader longitudinal research to evaluate female patients experiencing varying degrees of lifelong LDL cholesterol exposure, exploring whether the combination of hypercholesterolemia and gestational complications like pre-eclampsia highlights individuals facing exceptionally elevated long-term cardiovascular vulnerabilities. Such insights could assist in pinpointing female patients exposed to heightened cardiovascular dangers, determining whether they stand to gain from enhanced medical surveillance or more aggressive preventative interventions down the line.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.